These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 17076641)

  • 1. Saponins from Quillaja saponaria Molina: isolation, characterization and ability to form immuno stimulatory complexes (ISCOMs).
    Pham HL; Ross BP; McGeary RP; Shaw PN; Hewavitharana AK; Davies NM
    Curr Drug Deliv; 2006 Oct; 3(4):389-97. PubMed ID: 17076641
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Isolation and quantification of Quillaja saponaria Molina saponins and lipids in iscom-matrix and iscoms.
    Behboudi S; Morein B; Rönnberg B
    Vaccine; 1995 Dec; 13(17):1690-6. PubMed ID: 8719521
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hydration of lipid films with an aqueous solution of Quil A: a simple method for the preparation of immune-stimulating complexes.
    Copland MJ; Rades T; Davies NM
    Int J Pharm; 2000 Mar; 196(2):135-9. PubMed ID: 10699704
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preparation of immuno-stimulating complexes (ISCOMs) by ether injection.
    Pham HL; Shaw PN; Davies NM
    Int J Pharm; 2006 Mar; 310(1-2):196-202. PubMed ID: 16413713
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel ISCOMs from Quillaja brasiliensis saponins induce mucosal and systemic antibody production, T-cell responses and improved antigen uptake.
    Cibulski SP; Mourglia-Ettlin G; Teixeira TF; Quirici L; Roehe PM; Ferreira F; Silveira F
    Vaccine; 2016 Feb; 34(9):1162-71. PubMed ID: 26826546
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pseudo-ternary phase diagrams of aqueous mixtures of Quil A, cholesterol and phospholipid prepared by the lipid-film hydration method.
    Demana PH; Davies NM; Vosgerau U; Rades T
    Int J Pharm; 2004 Feb; 270(1-2):229-39. PubMed ID: 14726138
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immuno-stimulating complexes prepared by ethanol injection.
    Lendemans DG; Myschik J; Hook S; Rades T
    J Pharm Pharmacol; 2005 Jun; 57(6):729-33. PubMed ID: 15969927
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Saponins from
    Fleck JD; Betti AH; da Silva FP; Troian EA; Olivaro C; Ferreira F; Verza SG
    Molecules; 2019 Jan; 24(1):. PubMed ID: 30621160
    [No Abstract]   [Full Text] [Related]  

  • 9. Effects of carbohydrate modification of Quillaja saponaria Molina QH-B fraction on adjuvant activity, cholesterol-binding capacity and toxicity.
    Rönnberg B; Fekadu M; Behboudi S; Kenne L; Morein B
    Vaccine; 1997 Dec; 15(17-18):1820-6. PubMed ID: 9413088
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of Quil A on liposomal membranes.
    Paepenmüller T; Müller-Goymann CC
    Int J Pharm; 2014 Nov; 475(1-2):138-46. PubMed ID: 25107288
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quil A-lipid powder formulations releasing ISCOMs and related colloidal structures upon hydration.
    Demana PH; Davies NM; Hook S; Rades T
    J Control Release; 2005 Mar; 103(1):45-59. PubMed ID: 15710499
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Formulation of IMXQB: Nanoparticles Based on Quillaja brasiliensis Saponins to be Used as Vaccine Adjuvants.
    Rivera-Patron M; Cibulski SP; Miraballes I; Silveira F
    Methods Mol Biol; 2022; 2469():183-191. PubMed ID: 35508839
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis of cationic derivatives of Quil A and the preparation of cationic immune-stimulating complexes (ISCOMs).
    Pham HL; Ross BP; McGeary RP; Shaw PN; Davies NM
    Int J Pharm; 2009 Jul; 376(1-2):123-33. PubMed ID: 19375488
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Leaf saponins of Quillaja brasiliensis enhance long-term specific immune responses and promote dose-sparing effect in BVDV experimental vaccines.
    Cibulski S; Rivera-Patron M; Suárez N; Pirez M; Rossi S; Yendo AC; de Costa F; Gosmann G; Fett-Neto A; Roehe PM; Silveira F
    Vaccine; 2018 Jan; 36(1):55-65. PubMed ID: 29174676
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Solid-phase extraction NMR studies of chromatographic fractions of saponins from Quillaja saponaria.
    Nyberg NT; Baumann H; Kenne L
    Anal Chem; 2003 Jan; 75(2):268-74. PubMed ID: 12553761
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Saponin Interactions with Model Membrane Systems - Langmuir Monolayer Studies, Hemolysis and Formation of ISCOMs.
    de Groot C; Müller-Goymann CC
    Planta Med; 2016 Dec; 82(18):1496-1512. PubMed ID: 27760443
    [TBL] [Abstract][Full Text] [Related]  

  • 17. QS-21 Adjuvant: Laboratory-Scale Purification Method and Formulation Into Liposomes.
    Brunner L; Barnier-Quer C; Collin N
    Methods Mol Biol; 2017; 1494():73-86. PubMed ID: 27718186
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preparation and characterisation of quillaja saponin with less heterogeneity than Quil-A.
    Kamstrup S; San Martin R; Doberti A; Grande H; Dalsgaard K
    Vaccine; 2000 Apr; 18(21):2244-9. PubMed ID: 10717344
    [TBL] [Abstract][Full Text] [Related]  

  • 19. On the dilution behaviour of immuno-stimulating complexes (ISCOMs).
    Lendemans DG; Egert AM; Myschik J; Hook S; Rades T
    Pharmazie; 2006 Aug; 61(8):689-95. PubMed ID: 16964712
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cage-like complexes formed by DOTAP, Quil-A and cholesterol.
    Lendemans DG; Egert AM; Hook S; Rades T
    Int J Pharm; 2007 Mar; 332(1-2):192-5. PubMed ID: 17049770
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.